Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
4.50
+0.33 (7.91%)
Bozor ochiq: Aug 12, 2026, 3:56 PM EDT
4.44
+0.27 (6.47%)
Oldingi bozordan keyin: Aug 11, 2026, 5:50 PM EDT
Camp4 Therapeutics Corporation, klinik bosqichdagi biofarmatsevtika kompaniyasi, bir qator genetik kasalliklarni davolash uchun RNK asosidagi dorilarni kashf qiladi va ishlab chiqadi. Uning yetakchi mahsulot nomzod CMP-001, siydik aylanishi buzilishlarini davolash uchun 1/2 bosqichli klinik sinovda. Kompaniya shuningdek, SYNGAP1 bilan bog'liq buzilishlarni davolash uchun CMP-002ni ishlab chiqmoqda. Camp4 Therapeutics Corporation ilgari Marauder Therapeutics, Inc. nomi bilan tanilgan va 2018-yil mart oyida Camp4 Therapeutics Corporation nomini o'zgartirgan. Kompaniya 2015-yilda ro'yxatga olingan va shtab-kvartirasi Kembrij, Massachusetsda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Daniel Tardiff Ph.D. | Chief Scientific Officer |
| Dr. Leonard I. Zon M.D. | Founder & Chairman of Scientific Advisory Board |
| Dr. Richard A. Young Ph.D. | Founder & Independent Director |
| Dr. Satya Kuchimanchi Ph.D. | Senior Vice President of Technical Operations |
| Dr. Yuri Maricich M.B.A., M.D. | Chief Medical Officer |
| Mr. Caleb Moore | Chief Business Operations Officer |
| Mr. Joshua Mandel-Brehm | CEO, President & Director |
| Ms. Alla Sigova Ph.D. | Senior Vice President of Platform |
| Ms. Kelly Gold | Chief Financial Officer |
| Ms. Michelle Gates | Senior VP & Chief People Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-08-06 | S-3 | camp4-sx3.htm |
| 2026-08-04 | 8-K | camp-20260803.htm |
| 2026-07-27 | 8-K | camp-20260727.htm |
| 2026-06-12 | 8-K | camp-20260610.htm |
| 2026-05-14 | 8-K | camp-20260514.htm |
| 2026-05-07 | 8-K | camp-20260507.htm |
| 2026-04-23 | DEFA14A | defa14a-2026annualmeeting.htm |
| 2026-04-23 | DEF 14A | camp-20260422.htm |
| 2026-04-23 | ARS | formars-campx20251231x10k.pdf |
| 2026-03-24 | 8-K | camp-20260318.htm |